suspension buvable clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
DIMREATOX study - Reduction in digestive absorption of toxic substances by combined digestive decontamination in intensive care - randomized single-center study
This study looks at new ways to help people in intensive care who have accidentally taken dangerous substances. We want to see if special medicines can help remove these substances from the body faster and improve recovery. It's a small study to explore if this new approach works.
For: Major patients intoxicated by functional toxicant(s) · hospitalized in intensive care and intubated.France - AuthorisedTherapeutic use (Phase IV)
PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acute myeloid leukemia
This study looks at different medicines to prevent fungal infections in people with a type of blood cancer called acute myeloid leukaemia. It compares how well these medicines work over 6 months to keep people healthy.
For: Antifungal prophylaxis in patients with acute myeloid leukemiaBelgium · France - AuthorisedPhase I and Phase II (Integrated)- Other
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma
This study, BEACON 2, is looking for better ways to treat neuroblastoma, a type of cancer, in young people and adults when it has come back or not responded to previous treatments. It tests new combinations of existing medicines.
For: High risk relapsed neuroblastoma (relapsed or progressed after being defined as High Risk at any time following diagnosis or progressed/relapsed as high-risk neuroblastoma) · which is histologically proven as per International Neuroblastoma Staging System (INSS) definition.France · Austria · Germany